Up-regulating the expression of costimulatory molecules such as CD40, CD80/86, 4-1BBL, OX40L, CD70 and B7RP on the surface of myeloma cells can increase the susceptibility of myeloma cells to attack by immune effector cells. The gene discussed is CD80; the disease is plasma cell myeloma.